The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.
Please visit the COVID-19 & Cancer Resource Center where COVID-related content is freely available.
News from Cancer Discovery
- BDTX-1535 Goes After Osimertinib Resistance
EGFR inhibitor shows activity against C797S, other variants; could potentially treat brain metastases. - Targeting HER2 May Overtake Chemo, Immunotherapy in NSCLC
Trastuzumab deruxtecan and poziotinib show efficacy for patients with limited options. - Bicyclic Peptide Makes Targeting EphA2 Possible
Patients show favorable responses to novel drug, a first against the elusive target.
Advertisement
Trending - Altmetric
- Repurposing vandetanib plus everolimus for the treatment of ACVR1-mutant diffuse intrinsic pontine gliomaLast mentioned on Thu Oct 07 2021
- Integrative RNA-omics discovers GNAS alternative splicing as a phenotypic driver of splicing factor-mutant neoplasmsLast mentioned on Thu Oct 14 2021
- SMARCA4 inactivation promotes lineage-specific transformation and early metastatic features in the lungLast mentioned on Fri Oct 08 2021
- See more
